Huntington's disease and dementia: from structural changes to clinical issues

Huntington's disease and dementia: from structural changes to clinical issues

Bibliographic Details
Main Authors:	Nikolaou Theodoros, Beredimas Panagiotis, Krommyda Magdalini, Michos Andreas
Format:	Article
Language:	English
Published:	BMC 2008-04-01
Series:	Annals of General Psychiatry

Similar Items

Structural brain correlates of dementia in Huntington’s disease
by: Saul Martinez-Horta, et al.
Published: (2020-01-01)

Special Issue: Juvenile Onset Huntington’s Disease
by: Peg C. Nopoulos
Published: (2020-09-01)

Oxytocin in Huntington’s disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia
by: Sofia Bergh, et al.
Published: (2022-09-01)

Clinical presentation of juvenile Huntington disease
by: Ruocco Heloísa H., et al.
Published: (2006-01-01)

Huntington's disease: a clinical review
by: Roos Raymund AC
Published: (2010-12-01)

Early grey matter changes in structural covariance networks in Huntington's disease
by: Emma M. Coppen, et al.
Published: (2016-01-01)

Retinal and choroidal morphological changes in Huntington's disease
by: S. N. Svetozarskiy, et al.
Published: (2019-03-01)

Autonomic Changes in Juvenile-Onset Huntington’s Disease
by: Jordan L. Schultz, et al.
Published: (2020-08-01)

Comparative transcriptomics of choroid plexus in Alzheimer’s disease, frontotemporal dementia and Huntington’s disease: implications for CSF homeostasis
by: Edward G. Stopa, et al.
Published: (2018-05-01)

Identifying and verifying Huntington's disease subtypes: Clinical features, neuroimaging, and cytokine changes
by: Ling‐Xiao Cao, et al.
Published: (2024-03-01)

Huntington's Disease
by: J Gordon Millichap
Published: (1989-12-01)

Neuroinflammation in Huntington’s disease: From animal models to clinical therapeutics
by: Qingqing Jia, et al.
Published: (2022-12-01)

Case report: Clinical lycanthropy in Huntington's disease
by: Nick Medford, et al.
Published: (2023-01-01)

Huntington's disease: clinical aspects in 81 patients
by: Monica Santoro Haddad
Published: (1996-06-01)

Commentary: Acanthocytes identified in Huntington's disease
by: Kevin Peikert, et al.
Published: (2022-11-01)

Moderate Hyperhomocysteinemia in Patients with Huntington's Disease
by: Laich Andreas, et al.
Published: (2002-11-01)

Studying Huntington’s Disease in Yeast: From Mechanisms to Pharmacological Approaches
by: Sebastian Hofer, et al.
Published: (2018-09-01)

Factors contributing to clinical picture and progression of Huntington's disease
by: Daniel Zielonka
Published: (2018-01-01)

Clinical and Epidemiological Aspects of Huntington Disease in the Republic of Tatarstan
by: Sabina E. Munasipova, et al.
Published: (2020-06-01)

Exercise in Huntington's Disease: Current State and Clinical Significance
by: Sandro M. Mueller, et al.
Published: (2019-02-01)

Targeting Tau to Treat Clinical Features of Huntington's Disease
by: Maria Masnata, et al.
Published: (2020-11-01)

Huntington Disease in Asia
by: Miao Xu, et al.
Published: (2015-01-01)

Juvenile Huntington’s disease
by: G. E. Rudenskaya, et al.
Published: (2017-02-01)

Neurobiology of Huntington's Disease
by: Alan H. Sharp, et al.
Published: (1996-02-01)

Physiotherapy in Huntington’s disease
by: Hanne Ludt Fossmo, et al.
Published: (2013-01-01)

Investigating toxicity in Drosophila models of Huntington's Disease and Huntington's Disease-Like 2
by: Krench, Megan Attardo
Published: (2016)

Structural neuroimaging differentiates vulnerability from disease manifestation in colombian families with Huntington's disease
by: Maria del C. Valdés Hernández, et al.
Published: (2019-08-01)

511 Analysis of Clinical Outcome Assessments in Clinical Trials for Huntington’s Disease
by: James Kim, et al.
Published: (2024-04-01)

Juvenile Huntington's disease: a clinical case from a pediatric's practice
by: Emilia E. Alieva, et al.
Published: (2023-11-01)

“Clinical profile of genetically proven huntington's disease patients from Eastern India”
by: Zakir Hussain, et al.
Published: (2020-01-01)

Absence of Acanthocytosis in Huntington's Disease-like 2: A Prospective Comparison with Huntington's Disease
by: David G. Anderson, et al.
Published: (2017-12-01)

Supplemental Treatment for Huntington’s Disease with miR-132 that Is Deficient in Huntington’s Disease Brain
by: Masashi Fukuoka, et al.
Published: (2018-06-01)

Caspase-2 mRNA levels are not elevated in mild cognitive impairment, Alzheimer’s disease, Huntington’s disease, or Lewy Body dementia
by: Chris Hlynialuk, et al.
Published: (2022-01-01)

Caspase-2 mRNA levels are not elevated in mild cognitive impairment, Alzheimer's disease, Huntington's disease, or Lewy Body dementia.
by: Chris Hlynialuk, et al.
Published: (2022-01-01)

Dietary Flavonoids in the Management of Huntington’s Disease: Mechanism and Clinical Perspective
by: Haroon Khan, et al.
Published: (2020-02-01)

Clinical and genetic study of a juvenile⁃onset Huntington disease
by: Ying HAO, et al.
Published: (2012-06-01)

Premanifest Huntington's disease: Examination of oculomotor abnormalities in clinical practice.
by: Jessica Y Winder, et al.
Published: (2018-01-01)

The role of transcription and RNA/DNA structures in the pathology of Huntington's disease
by: Beghè, C
Published: (2023)

Excitotoxic mechanisms in Huntington's disease
by: Freese, Andrew
Published: (2005)

Cortical myoclonus in Huntington's disease.
by: Thompson, P, et al.
Published: (1994)